Product
BBV154
Aliases
BBV154 Intranasal Vaccine
2 clinical trials
2 indications
Indication
Coronavirus InfectionIndication
COVID-19Clinical trial
Phase 2 Randomized, Multi-centric of Heterologus Prime-Boost Combination of SARS-CoV-2 Vaccines to Evaluate the Immunogenicity and Safety of BBV152 (COVAXIN®) With BBV154 (Adenoviral Intranasal COVID-19 Vaccine) in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-03-01
Clinical trial
Phase 3, Randomized, Multi-Centric, Open-labeled Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose in Participants Previously Vaccinated With EUA VaccinesStatus: Completed, Estimated PCD: 2022-05-03